Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.37−0.37 (-2.09%)
Close on Nov 18, 2026Market cap $474.25MP/E –Yield –
Carlsmed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Carlsmed's revenue for the twelve months ending Jun 30, 2026 was $63.30M, up 65.4% year over year. For fiscal 2025 it was $50.51M, up 85.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.51M | +85.9% |
| FY2024 | Dec 31, 2024 | $27.17M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.94M | +56.7% |
| Q1 FY2026 | Mar 31, 2026 | $16.12M | +58.2% |
| Q4 FY2025 | Dec 31, 2025 | $15.17M | +61.2% |
| Q3 FY2025 | Sep 30, 2025 | $13.07M | +98.4% |
| Q2 FY2025 | Jun 30, 2025 | $12.08M | +98.7% |
| Q1 FY2025 | Mar 31, 2025 | $10.19M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.41M | – |
| Q3 FY2024 | Sep 30, 2024 | $6.59M | – |
| Q2 FY2024 | Jun 30, 2024 | $6.08M | – |
See a number that looks wrong?